These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20389132

  • 1. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
    Matthews AJ, Bruno R.
    Neuropsychobiology; 2010; 61(4):215-22. PubMed ID: 20389132
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA, Degenhardt L.
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users.
    Scott LA, Roxburgh A, Bruno R, Matthews A, Burns L.
    Addict Behav; 2012 Sep; 37(9):1058-62. PubMed ID: 22607716
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K, Turner JJ, Parrott AC.
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM, Parrott AC, Schifano F, Turner JJ.
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [Abstract] [Full Text] [Related]

  • 14. Pills and pints: risky drinking and alcohol-related harms among regular ecstasy users in Australia.
    Kinner SA, George J, Johnston J, Dunn M, Degenhardt L.
    Drug Alcohol Rev; 2012 May; 31(3):273-80. PubMed ID: 21919977
    [Abstract] [Full Text] [Related]

  • 15. Major depression: the relative contribution of gender, MDMA, and cannabis use.
    Durdle H, Lundahl LH, Johanson CE, Tancer M.
    Depress Anxiety; 2008 May; 25(3):241-7. PubMed ID: 17345601
    [Abstract] [Full Text] [Related]

  • 16. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 17. Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis.
    Sumnall HR, Cole JC.
    J Psychopharmacol; 2005 Jan; 19(1):84-92. PubMed ID: 15671133
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
    Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J.
    Hum Psychopharmacol; 2002 Aug; 17(6):309-12. PubMed ID: 12404677
    [Abstract] [Full Text] [Related]

  • 20. The epidemiology of ecstasy use and harms in Australia.
    Degenhardt L, Roxburgh A, Dunn M, Campbell G, Bruno R, Kinner SA, George J, Quinn B, White N, Topp L.
    Neuropsychobiology; 2009 Aug; 60(3-4):176-87. PubMed ID: 19893334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.